Accelerating Data Solutions to Save LIVES from COVID-19

The consortium of COVID-X announces the launch of the ​1st Open Call ​framed in a ​2-year initiative that will invest ​4 million € to fast-track to market 30+ European data technology solutions defeating COVID-19 Challenges, facilitating an innovative stack of AI-driven tools.

COVID-19 pandemic is hitting with force. Europe has passed the threshold of ​250,000 deaths since February 2020.​ COVID-X takes the battle against corona virus to a new level by bridging the gap between the European digital sector and the healthcare system. The program will unlock the full capacity of Artificial Intelligence and Data to fight COVID-19​, validating, and scaling up breakthroughs to save lives.

COVID-X will fund EU Companies and Healthcare Providers to boost data-driven solutions with the power to overcome challenges in Diagnosis, Prognosis, and Follow-up. The funding is invested in products with TRL7+ and [or in the process of] CE marking, covering two profiles: single players (EU Tech SMEs / Start-Ups) validating their solutions at one of COVID-X clinical partners; or ​multiplayers (Tech Provider working with a Healthcare provider that will validate the solution). The selected projects will join an Acceleration Program to boost their quick market uptake. ​This will include technical support, ethical validation, and business coaching.

In addition, participants will have access to the ​COVID-X Sandbox​, a one-stop platform to exploit COVID-19 data sources, incorporating general information on data silos, as well as the integration, visualization, and exploratory analysis for easy understanding. The 1st Open Call Application is now open and the deadline will be on​ the 27th January 2021.

For further information, please visit:
https://www.covid-x.eu

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...